For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
Ronald Blasberg’s laboratory in the Molecular Pharmacology Program focuses on the development of preclinical, noninvasive, multimodality reporter-gene imaging and its translation into a clinical application. These approaches utilize modern molecular biology, cancer biology, and imaging (MRI, optical imaging, PET, and SPECT) techniques.
